Zhong Guo Jing Ji Wang·2025-10-22 02:36Core Viewpoint - Ningbo Jianxin Superconducting Technology Co., Ltd. has been approved for its initial public offering (IPO) on the Shanghai Stock Exchange, marking it as the 61st company to pass the review this year [1][2]. Company Overview - Jianxin Superconducting specializes in the research, production, and sales of core components for medical magnetic resonance imaging (MRI) equipment, including superconducting magnets, permanent magnets, and gradient coils, which account for approximately 50% of the cost of MRI core components [1][2]. - The company plans to raise 775 million yuan (approximately 77.5 million) for projects including the annual production of 600 sets of liquid helium-free superconducting magnets and the technological transformation of high-field medical superconducting magnets [2]. Shareholding Structure - Xu Jianyi directly holds 41.51% of the company's shares, making him the controlling shareholder. His family members, Xu Hui and Xu Dianbo, hold 4.36% each, with additional control through Kai Fang Investment and Qi Yi Investment, resulting in a combined control of 59.92% of the voting rights [2]. Market and Competitive Landscape - The listing committee inquired about the market space, competitive landscape, and future development trends of the MRI equipment and superconducting magnet market, emphasizing the stability of the independent supplier business model compared to in-house production [3].